Belgium is the world's leading exporter of vaccines, generating 22 billion euros by 2023, ahead of the United States and Ireland. This world-leading position was highlighted by the bio.be/essenscia industry federation at its annual event held today at Egmont Palace. After supplying a large part of the world's population during the Covid-19 crisis, thanks to the export of billions of vaccines, these figures once again demonstrate Belgium's status as the undisputed world leader in vaccines. To maintain this position of international leadership in the development, production and distribution of vaccines and medicines, bio.be/essenscia advocates the deployment of an ambitious pharma and biotech strategy covering the entire value chain, from lab to patient.